Código QR (código de barras bidimensional)

Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab versus neoadjuvant chemotherapy plus tislelizumab for locally advanced esophageal squamous cell cancer: a real-world retrospective study

BackgroundWhile neoadjuvant chemoimmunotherapy shows promise for locally advanced esophageal squamous cell carcinoma (ESCC), optimal regimen selection remains challenging. This study compares perioperative outcomes between camrelizumab- and tislelizumab-based neoadjuvant chemoimmunotherapy in ESCC.M...

ver descrição completa

Na minha lista:
Principais autores: Qi Zhao, Yusen Yuan, Tongxin Xu, Ningning Yan, Fei Li, Juntao Lu, Ming He, Zhaoyang Yan
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2025-08-01
coleção:Frontiers in Immunology
Assuntos:
esophageal squamous cell carcinoma
neoadjuvant therapy
tislelizumab
camrelizumab
immunotherapy
esophagectomy
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1544739/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados